News
South African Tuberculosis Vaccine Initiative (SATVI), located within Infectious Disease and Molecular Medicine (IDM) at the Faculty of Health Sciences invites applications from suitably qualified candidates for a 24-month contract position of Laboratory Technologist based in Worcester.
SATVI authors have published research in which they find that the implementation of optimized procedures and a more rigorous QuantiFERON-TB conversion definition, an increase from IFNy<0.2 to >0.7 IU/mL, would allow more definitive detection of recent M.tb infection and potentially improve identification of those more likely to develop disease.
On Thursday 3 August the South African Tuberculosis Vaccine Initiative hosted a delegation from the Cape Winelands Education TB & HIV Program.
SATVI authors Professor Mark Hatherill, Associate Professor Tom Scriba, Drs. Munyaradzi Musvosvi and Virginie Rozoton have co-authored a research paper titled "Differential recognition of Mtb-specific epitopes as a function of tuberculosis disease history" appearing in the American Journal of Respiratory and Critical Care Medicine.
Pages
SATVI Worcester Site Office:
SATVI Project Office, University of Cape Town, Brewelskloof Hospital, Haarlem Street, WORCESTER, 6850.
Tel: +27 23 346 5400
Fax: +27 23 346 5406
Email: Field Site Manager
GPS coordinates -33.620455, 19.458576
Map to Worcester Field Office